2015-2019 New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape is VPGMarketResearchs new report, which provides comprehensive analysis of thePOC hematology and flow cytometry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
- Review of POC hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts forhematology and flow cytometry procedures by market
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers
Sales and Market Share Analysis
- Sales and market shares ofmajor reagent and instrument suppliers.
Routine and Special Hematology Tests
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual),
Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual),
Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils and others.
Flow Cytometry Tests
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing POC diagnostic technologies
and products, by test.
- Specific opportunities for new POC instruments and reagent systems with potentially
significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
- Assessments of major suppliers and emerging market entrants, including their sales, product
portfolios, marketing tactics, joint ventures, and new products in R&D.
- The companies analyzed in the report include:
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Iris Diagnostics/Danaher
- Nihon Kohden
- Ortho-Clinical Diagnostics
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.
Contains 279 pages and58 tables
SIMILAR MARKET STUDIES
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023
DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, ...
May 2017 | $5370 | View Details >>
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimerâ€™s disease, Parkinson disease, and other neurological disorders.
May 2017 | $5370 | View Details >>
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-BarrÃ© Syndrome, Kawasaki Disease, Secondary Immune Deficiency, And Other Applications), Mode of Delivery (Intravenous, Intramuscular, Subcutaneous), and Concentration (5%, 10% and Other Concentration): Opportunity Analysis and Industry Forecast, 2014-2022
Intravenous immunoglobulin (IVIG) is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. IVIG is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.
May 2017 | $2850 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research